definiens: means ( a ) the Listed [COMPANY] Patents, ( b ) all othe r Patents ( including [COMPANY] ’s interest in any Joint Collaboration Invent ion Patents meeting the requirements of the rest of this clause ( b ) ) Controlled by [COMPANY] or its Affiliate during t he Term and claiming priority to a Patent in existe nce prior to the end of the Pre - Sublicensing Term that Cover Lic ensed Antibody and/or Licensed Product, and ( c ) all Post - Partnering Patents claiming priority to a Patent fi rst filed during the Pre - Sublicensing Term, but exc luding after a [COMPANY] Change of Control all Patents of the acquiro r and/or the acquiring corporate family existing pr ior to or on the date of such [COMPANY] Change of Control, claiming priority to such a Patent existing prior or on suc h date, or owned or controlled by such acquirer and/or the acq uiring corporate family independently of [COMPANY] ( fo r clarity, in the case where [COMPANY] is merged into another ent ity, the references here to and mean to refer to and ) . For the avoida nce of doubt, all Patents that qualified as Licensed Paten ts prior to the date of such [COMPANY] Change of Contr ol shall remain part of Licensed Patents during the Term . To avoid doubt, Licensed Patents exclude [ … * * * … ]